Opendata, web and dolomites

T-NHL SUPRESSORS SIGNED

Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 T-NHL SUPRESSORS project word cloud

Explore the words cloud of the T-NHL SUPRESSORS project. It provides you a very rough idea of what is the project "T-NHL SUPRESSORS" about.

hallmark    identification    model    regulatory    enforced    sensing    pd    effector    conventional    30    lymphoma    lymphomas    fundamental    undefined    enforce    molecular    events    additionally    oncogenic    cancers    tcr    host    hodgkin    mature    haploinsufficient    receptor    explore    antigen    inactivated    independent    entities    experimental    mechanisms    counteract    signaling    therapies    limited    activation    nhl    variants    multiple       regulators    malignancies    insights    drive    pathomechanisms    continuous    pathogenesis    vivo    sub    inhibit    aggressive    hypothesis    physiological    human    defense    negative    thereby    dependent    function    overarching    significantly    inhibitory    functions    resistant    clone    gain    manner    programs    lymphomagenesis    expansion    cell    mutations    suppressor    proliferation    constitutive    largely    dissect    understudied    molecules    comprehensively    survival    tumor    immune    presumably    mediated    nhls    oncogenically    malignant    cells   

Project "T-NHL SUPRESSORS" data sheet

The following table provides information about the project.

Coordinator
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN 

Organization address
address: ISMANINGER STRASSE 22
city: MUENCHEN
postcode: 81675
website: http://www.med.tu.muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 2˙492˙937 €
 EC max contribution 2˙492˙937 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-ADG
 Funding Scheme ERC-ADG
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2024-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) coordinator 2˙492˙937.00

Map

 Project objective

T cell non-Hodgkin lymphomas (T-NHLs) are highly aggressive malignancies that are largely resistant to conventional therapies. T-NHLs remain significantly understudied, and their molecular pathogenesis is still not well defined. Comprehensive analysis of mature T-cell lymphomas has identified multiple gain-of-function mutations in T-cell receptor (TCR) signaling molecules as an overarching hallmark of T-NHL sub-entities. Under physiological conditions, these molecules control the expansion, survival and effector function of antigen sensing T cells for host defense. Presumably, the oncogenic TCR signaling variants in lymphoma enforce these TCR programs in a constitutive manner and thereby drive continuous proliferation and expansion of the malignant clone. However, experimental in vivo evidence for this hypothesis is still limited, and the negative regulatory tumor suppressor mechanisms that can counteract oncogenic T cell signaling remain largely undefined. We recently identified the inhibitory immune receptor PD-1 as a key haploinsufficient tumor suppressor in T-cell lymphoma that is inactivated in up to 30% of human cases. The overall goal of this proposal is to comprehensively model and dissect T-cell lymphomagenesis driven by oncogenically enforced T-cell receptor pathways and to identify the PD-1 dependent and independent tumor suppressor mechanisms that inhibit these events. We will additionally explore the functions of new negative regulators within the PD-1 pathway or related pathways in antigen-mediated T cell activation. We expect that our results will provide fundamental new insights into the molecular pathomechanisms of highly aggressive T cell cancers and additionally lead to the identification of new negative regulators of antigen-mediated T cell activation.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "T-NHL SUPRESSORS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "T-NHL SUPRESSORS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ZARAH (2020)

Women’s labour activism in Eastern Europe and transnationally, from the age of empires to the late 20th century

Read More  

ChaperoneRegulome (2020)

ChaperoneRegulome: Understanding cell-type-specificity of chaperone regulation

Read More  

MOCHA (2019)

Understanding and leveraging ‘moments of change’ for pro-environmental behaviour shifts

Read More